Blauvelt, A, RB Warren, K Reich, and et al. “Durable Improvement in Patient Reported Outcomes across DLQI Subdomains Over 48 Weeks in Chronic Plaque Psoriasis Patients Treated With Certolizumab Pegol in Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”. SKIN The Journal of Cutaneous Medicine 3, no. 2 (March 11, 2019): 175. Accessed September 20, 2024. https://dermsquared.com/skin/article/view/532.